ATE501280T1 - Verfahren zum nachweis eines analyten in einer biologischen matrix - Google Patents

Verfahren zum nachweis eines analyten in einer biologischen matrix

Info

Publication number
ATE501280T1
ATE501280T1 AT07727792T AT07727792T ATE501280T1 AT E501280 T1 ATE501280 T1 AT E501280T1 AT 07727792 T AT07727792 T AT 07727792T AT 07727792 T AT07727792 T AT 07727792T AT E501280 T1 ATE501280 T1 AT E501280T1
Authority
AT
Austria
Prior art keywords
analyte
detecting
biological matrix
sample
dilution buffer
Prior art date
Application number
AT07727792T
Other languages
English (en)
Inventor
Michael Adler
Original Assignee
Chimera Biotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38462758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE501280(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chimera Biotec Gmbh filed Critical Chimera Biotec Gmbh
Application granted granted Critical
Publication of ATE501280T1 publication Critical patent/ATE501280T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07727792T 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix ATE501280T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/053323 WO2008122310A1 (en) 2007-04-04 2007-04-04 Method for the detection of an analyte in biological matrix

Publications (1)

Publication Number Publication Date
ATE501280T1 true ATE501280T1 (de) 2011-03-15

Family

ID=38462758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727792T ATE501280T1 (de) 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix

Country Status (6)

Country Link
US (1) US20100291562A1 (de)
EP (1) EP2132339B1 (de)
AT (1) ATE501280T1 (de)
DE (1) DE602007013110D1 (de)
DK (1) DK2132339T3 (de)
WO (1) WO2008122310A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008047790A1 (de) * 2008-09-17 2010-04-15 Qiagen Gmbh Verfahren zur Normierung des Gehalts von Biomolekülen in einer Probe
WO2010078443A1 (en) 2008-12-31 2010-07-08 Abbott Point Of Care Inc. Method and device for immunoassay using nucleotide conjugates
WO2011047087A2 (en) * 2009-10-13 2011-04-21 Nanostring Technologies, Inc. Protein detection via nanoreporters
GB201011971D0 (en) 2010-07-15 2010-09-01 Olink Ab Methods and product
JP5852334B2 (ja) * 2011-06-07 2016-02-03 株式会社日立ハイテクノロジーズ 自動分析方法
DE102014010333A1 (de) 2014-07-14 2016-01-14 Qiagen Gmbh Verfahren zum Nachweis wenigstens eines Zielanalyten in einer Probe
CN107208136A (zh) * 2014-12-18 2017-09-26 通用电气医疗集团英国有限公司 通过与免疫测定法偶联的核酸扩增的固体支持物上的分析物检测
CN113376364B (zh) 2015-08-10 2025-02-25 上海宜晟生物科技有限公司 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法
MX392709B (es) 2015-09-14 2025-03-24 Essenlix Corp Dispositivo y sistema para recolectar y analizar condensado de vapor, particularmente condensado de exhalación de la respiración y un método para usarlo.
WO2017048871A1 (en) 2015-09-14 2017-03-23 Essenlix Corp. Device and system for analyzing a sample, particularly blood, as well as methods of using the same
CN110312473B (zh) 2016-12-21 2023-04-07 艾森利克斯公司 用于认证样本的装置和方法及其使用
JP7003158B2 (ja) 2017-02-07 2022-01-20 エッセンリックス コーポレーション 圧縮開放流アッセイおよび使用
US10823645B2 (en) 2017-02-08 2020-11-03 Essenlix Corporation Sample collection and handling for delayed analysis
CN120685901A (zh) 2017-02-08 2025-09-23 上海宜晟生物科技有限公司 数字测定
WO2018148469A1 (en) 2017-02-08 2018-08-16 Essenlix Corp. Bio/chemical material extraction and assay
CA3052986A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Molecular manipulation and assay with controlled temperature
CA3052809A1 (en) 2017-02-08 2018-08-23 Essenlix Corporation Qmax assays and applications
WO2018148607A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Assay using different spacing heights
CA3053132A1 (en) 2017-02-09 2018-08-16 Essenlix Corp. Assay with amplification
US11604148B2 (en) 2017-02-09 2023-03-14 Essenlix Corporation Colorimetric assays
US12350680B2 (en) 2017-02-15 2025-07-08 Essenlix Corporation Assay with rapid temperature change
US11523752B2 (en) 2017-02-16 2022-12-13 Essenlix Corporation Assay for vapor condensates
BR112019026335A2 (pt) 2017-06-12 2020-07-21 Essenlix Corporation ensaio homogêneo
US11243201B2 (en) 2017-08-01 2022-02-08 Essenlix Corporation Sample collection, holding and assaying
WO2019028133A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation DEVICES AND METHODS FOR EXAMINING THE EFFECTS OF MEDICINE ON MICROORGANISMS
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
WO2019075244A1 (en) 2017-10-11 2019-04-18 Essenlix Corporation CONTAINING A LIQUID SAMPLE
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
US11510608B2 (en) 2017-12-14 2022-11-29 Essenlix Corporation Devices, systems, and methods for monitoring hair
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ES2259800T3 (es) * 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
US5496938A (en) * 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
CA2095633C (en) * 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
EP0529070A1 (de) * 1991-02-27 1993-03-03 Amoco Corporation Verfahren zur verbesserung der empfindlichkeit von hybridisierungsassays
ATE414768T1 (de) * 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
DE69333115D1 (de) * 1992-09-22 2003-08-28 Biofocus Discovery Ltd Rekombinante viren, die an ihrer äusseren oberfläche ein nichtvirales polypeptid präsentieren
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5496398A (en) * 1994-10-28 1996-03-05 Thiele Kaolin Company Reduction of microorganisms in kaolin clay slurries
US5702892A (en) * 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
US6665317B1 (en) * 1999-10-29 2003-12-16 Array Telecom Corporation Method, system, and computer program product for managing jitter
EP1660858A4 (de) * 2003-07-21 2007-10-24 Amplified Proteomics Inc Multiplex-analytnachweis

Also Published As

Publication number Publication date
EP2132339A1 (de) 2009-12-16
EP2132339B1 (de) 2011-03-09
DE602007013110D1 (de) 2011-04-21
DK2132339T3 (da) 2011-06-27
US20100291562A1 (en) 2010-11-18
WO2008122310A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
ATE501280T1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
EP4286055C0 (de) Verfahren zur bestimmung des vorhandenseins von mehreren formen eines nukleinsäureanalyten in einer probe
EP2883037C0 (de) Verfahren und vorrichtung zur durchführung und quantifizierung von farbveränderungen durch spezifische konzentrationen von biologischen analyten in einer automatisch kalibrierten umgebung
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
ATE479780T1 (de) Qpcr unter verwendung eines ionen-sensitiven feldeffekt-transistors zur ph-messung
BR112017021256A2 (pt) dispositivos e métodos para a análise de amostras
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
ZA201403386B (en) A method of detecting and/or quantifying an analyte in a biological sample
MY170164A (en) Aptamer-based multiplexed assays
WO2013157917A3 (en) A biosensor and preparation method thereof
GB2458855A (en) Detection device and methods of use
EP2449129A4 (de) Verfahren zur bestimmung des vorhandenseins und/oder der konzentration eines analyts in einer probe
EP2772761A3 (de) Nukleinsäureelement zur Verwendung für Analysen sowie Analyseverfahren, Analysereagens und Analyseinstrument damit
EA201071134A1 (ru) Анализ днк посредством капиллярного электрофореза
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
ATE541216T1 (de) Fluoreszenztestverfahren
AT10236U3 (de) Messanordnung und verfahren zur erfassung von messdaten
DE602006011917D1 (de) Verfahren und substanzen zur isolierung von mirnas
EP2596121A4 (de) Verfahren zur verknüpfung der ergebnisse von diagnosetests an einem point of care mit laborbasierten verfahren
IN2014KN01352A (de)
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
ATE519107T1 (de) Verfahren zur tacrolimus-extraktion und - quantifizierung unter verwendung wässriger detergentien
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties